Pioglitazone
Pricing Report NDC 63304-313-05

Latest NADAC: $0.24623 per EA · Effective May 20, 2015 · Est. package price $123.12 (500 EA)
Table of Contents
  1. Current Pricing Information
  2. Pricing History

Current Package Pricing Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

The latest wholesale acquisition cost for Pioglitazone (NDC 63304-313-05) is $0.24623 per EA. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since May 20, 2015.

As a provided by Ranbaxy Pharmaceuticals Inc., this medication is distributed in a 500 TABLET in 1 BOTTLE configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$0.24623
Per EA

Pricing Unit
Per EA Pricing Unit
Indicates the billing unit (ML, GM or EA).
Effective Date
May 20, 2015
Billable Units
500 EA
Estimated Package Price
$123.12
Data Status
As of May 20, 2015
Pharmacy Source Pharmacy Type Indicator
Data collected from Chain/Independent pharmacy surveys.
C/I - Chain or Independent Pharmacy
Rate Classification Classification for Rate Setting
Indicates if the NDC is Brand (B) or Generic (G).
G - Generic
Package NDC
63304-313-05
Description
500 TABLET in 1 BOTTLE
Pricing Methodology Explanation
The NADAC was calculated using information from the most recently completed pharmacy survey.
The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Nov 2013, the NADAC wholesale price for (NDC ) has moved within a range of $0.18546 to $0.30639 per EA. Over this 2 years and 7 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$0.1855 - $0.3064
Market Volatility
65.21% Variance
Latest Trend
7.92%

Recent NADAC Price History

DateUnit PriceUnitSourceMethodRate
Jul 20, 2016 $0.20015 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jun 22, 2016 $0.18546 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jun 22, 2016 $0.18546 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
May 18, 2016 $0.21372 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
May 18, 2016 $0.21372 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Apr 20, 2016 $0.22354 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Apr 20, 2016 $0.22354 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Mar 23, 2016 $0.22458 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Mar 23, 2016 $0.22458 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Feb 17, 2016 $0.22299 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Feb 17, 2016 $0.22299 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jan 20, 2016 $0.21081 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic

Earlier NADAC Price History

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.

Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: September 09, 2026